123 related articles for article (PubMed ID: 25539072)
1. Fangchinoline as a kinase inhibitor targets FAK and suppresses FAK-mediated signaling pathway in A549.
Guo B; Su J; Zhang T; Wang K; Li X
J Drug Target; 2015 Apr; 23(3):266-74. PubMed ID: 25539072
[TBL] [Abstract][Full Text] [Related]
2. Fangchinoline suppresses growth and metastasis of melanoma cells by inhibiting the phosphorylation of FAK.
Shi J; Guo B; Hui Q; Chang P; Tao K
Oncol Rep; 2017 Jul; 38(1):63-70. PubMed ID: 28560386
[TBL] [Abstract][Full Text] [Related]
3. Fangchinoline suppresses the growth and invasion of human glioblastoma cells by inhibiting the kinase activity of Akt and Akt-mediated signaling cascades.
Guo B; Xie P; Su J; Zhang T; Li X; Liang G
Tumour Biol; 2016 Feb; 37(2):2709-19. PubMed ID: 26408176
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Potential of Focal Adhesion Kinase Inhibition in Small Cell Lung Cancer.
Aboubakar Nana F; Lecocq M; Ladjemi MZ; Detry B; Dupasquier S; Feron O; Massion PP; Sibille Y; Pilette C; Ocak S
Mol Cancer Ther; 2019 Jan; 18(1):17-27. PubMed ID: 30352800
[TBL] [Abstract][Full Text] [Related]
5. Enterolactone alters FAK-Src signaling and suppresses migration and invasion of lung cancer cell lines.
Chikara S; Lindsey K; Borowicz P; Christofidou-Solomidou M; Reindl KM
BMC Complement Altern Med; 2017 Jan; 17(1):30. PubMed ID: 28068967
[TBL] [Abstract][Full Text] [Related]
6. Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells.
Tian F; Ding D; Li D
Int J Oncol; 2015; 46(6):2355-63. PubMed ID: 25872479
[TBL] [Abstract][Full Text] [Related]
7. Fangchinoline suppresses the proliferation, invasion and tumorigenesis of human osteosarcoma cells through the inhibition of PI3K and downstream signaling pathways.
Li X; Yang Z; Han W; Lu X; Jin S; Yang W; Li J; He W; Qian Y
Int J Mol Med; 2017 Aug; 40(2):311-318. PubMed ID: 28586029
[TBL] [Abstract][Full Text] [Related]
8. Rho-associated kinase signaling is required for osteopontin-induced cell invasion through inactivating cofilin in human non-small cell lung cancer cell lines.
Kang CG; Han HJ; Lee HJ; Kim SH; Lee EO
Bioorg Med Chem Lett; 2015 May; 25(9):1956-60. PubMed ID: 25817589
[TBL] [Abstract][Full Text] [Related]
9. A novel sialyltransferase inhibitor suppresses FAK/paxillin signaling and cancer angiogenesis and metastasis pathways.
Chen JY; Tang YA; Huang SM; Juan HF; Wu LW; Sun YC; Wang SC; Wu KW; Balraj G; Chang TT; Li WS; Cheng HC; Wang YC
Cancer Res; 2011 Jan; 71(2):473-83. PubMed ID: 21224350
[TBL] [Abstract][Full Text] [Related]
10. Plumbagin reduces osteopontin-induced invasion through inhibiting the Rho-associated kinase signaling pathway in A549 cells and suppresses osteopontin-induced lung metastasis in BalB/c mice.
Kang CG; Im E; Lee HJ; Lee EO
Bioorg Med Chem Lett; 2017 May; 27(9):1914-1918. PubMed ID: 28359791
[TBL] [Abstract][Full Text] [Related]
11. The Rho-kinase inhibitor inhibits proliferation and metastasis of small cell lung cancer.
Yang X; Di J; Zhang Y; Zhang S; Lu J; Liu J; Shi W
Biomed Pharmacother; 2012 Apr; 66(3):221-7. PubMed ID: 22425182
[TBL] [Abstract][Full Text] [Related]
12. Smilax glabra Roxb targets Akt(p-Thr308) and inhibits Akt-mediated signaling pathways in SGC7901 cells.
Hao G; Zheng J; Huo R; Li J; Wen K; Zhang Y; Liang G
J Drug Target; 2016; 24(6):557-65. PubMed ID: 26607178
[TBL] [Abstract][Full Text] [Related]
13. Glabridin inhibits migration, invasion, and angiogenesis of human non-small cell lung cancer A549 cells by inhibiting the FAK/rho signaling pathway.
Tsai YM; Yang CJ; Hsu YL; Wu LY; Tsai YC; Hung JY; Lien CT; Huang MS; Kuo PL
Integr Cancer Ther; 2011 Dec; 10(4):341-9. PubMed ID: 21059620
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion.
Meng XN; Jin Y; Yu Y; Bai J; Liu GY; Zhu J; Zhao YZ; Wang Z; Chen F; Lee KY; Fu SB
Br J Cancer; 2009 Jul; 101(2):327-34. PubMed ID: 19568240
[TBL] [Abstract][Full Text] [Related]
15. Targeting FAK radiosensitizes 3-dimensional grown human HNSCC cells through reduced Akt1 and MEK1/2 signaling.
Hehlgans S; Eke I; Cordes N
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e669-76. PubMed ID: 22483702
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effects of tyroservatide on metastasis of lung cancer and its mechanism affecting integrin-focal adhesion kinase signal transduction.
Huang YT; Zhao L; Fu Z; Zhao M; Song XM; Jia J; Wang S; Li JP; Zhu ZF; Lin G; Lu R; Yao Z
Drug Des Devel Ther; 2016; 10():649-63. PubMed ID: 27041993
[TBL] [Abstract][Full Text] [Related]
17. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X
J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760
[TBL] [Abstract][Full Text] [Related]
18. Genistein inhibits the growth and regulates the migration and invasion abilities of melanoma cells via the FAK/paxillin and MAPK pathways.
Cui S; Wang J; Wu Q; Qian J; Yang C; Bo P
Oncotarget; 2017 Mar; 8(13):21674-21691. PubMed ID: 28423510
[TBL] [Abstract][Full Text] [Related]
19. Alpha-mangostin suppresses phorbol 12-myristate 13-acetate-induced MMP-2/MMP-9 expressions via alphavbeta3 integrin/FAK/ERK and NF-kappaB signaling pathway in human lung adenocarcinoma A549 cells.
Shih YW; Chien ST; Chen PS; Lee JH; Wu SH; Yin LT
Cell Biochem Biophys; 2010 Sep; 58(1):31-44. PubMed ID: 20652762
[TBL] [Abstract][Full Text] [Related]
20. Galangin inhibits tumor growth and metastasis of B16F10 melanoma.
Zhang W; Tang B; Huang Q; Hua Z
J Cell Biochem; 2013 Jan; 114(1):152-61. PubMed ID: 22887049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
